As Use of PSA Test Fell, Rate of Advanced Prostate Cancers Rose
WEDNESDAY, March 16, 2022 (HealthDay News) — Ever since routine prostate-specific antigen (PSA) screening tests have no longer been recommended, there has been a troubling rise in advanced prostate cancer cases in the United States, new research has found. The tests measure the amount of PSA in the blood, andContinue Reading